Biden administration picks 15 more drugs for Medicare negotiation
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule.
Administration officials did not share which drugs had been selected, only saying in a briefing that the 15 that had been chosen, combined with the 10 that have already been negotiated on, represent a third of Medicare Part D spending.
CMS had until Feb. 1 to announce the new batch of drugs chosen for negotiation. When asked if the new selection was announced early in anticipation of the incoming Trump administration, a senior administration official noted CMS had completed actions related to Medicare negotiations ahead of set deadlines in the past.
The agency will announce the 15 new drugs chosen for Medicare negotiation on Friday morning. The companies that manufacture these drugs will have until Feb. 28 to sign negotiation agreement.
Health and Human Services Secretary Xavier Becerra called the announcement a "great way to close out the four-year term of the president."
"I need to remind people the President made a pretty direct promise more than four years ago, when he was campaigning [...], he said he would lower prescription drug costs, and he delivered," he added.
The Biden administration has long held Medicare negotiations as one of its key health care accomplishments. The first round of negotiations were completed last year, with officials saying the talks will save an estimated $6 billion in savings for Medicare.
Through negotiations, CMS got discounts on the first 10 drugs ranging from about 40 to 80 percent off the list prices. The lowered prices for the first 10 drugs will go into effect beginning in 2026. Because Medicare does not disclose the net price it pays for drugs, the true savings are unclear.
"Today, I’m proud to announce that my Administration has selected the next 15 drugs for Medicare drug price negotiation. The drugs treat conditions such as diabetes and cancer, and seniors across the country rely on them," President Biden said in a statement.
"The Inflation Reduction Act put the country on a path to lower drug prices. I’m proud of my Administration’s implementation of this law to deliver lower prices for America’s seniors," he added.
Many drugs covered by Medicare are exempt from negotiations, including those that have generic or biosimilar versions available; drugs less than seven years old; biological products less than 11 years old; and orphan drugs, which are used to treat rare diseases and are not expected to generate profit.
The drugs that are chosen represent the highest total Medicare Part B and D spending.
"The 15 drugs selected for the second round of negotiation account for about $41 billion of total Medicare prescription drug spending. When combined with the first round of negotiation, it is clear that the success of the Medicare drug negotiation program has been nothing short of remarkable," CMS Administrator Chiquita Brooks-LaSure said.
Senior administration officials declined to speculate on how the Trump administration may change or pause the Medicare drug price negotiation program.
Topics
-
Ozempic among drugs targeted in upcoming Medicare price negotiations
Investors fret Novo Nordisk’s blockbuster treatments and other medicines could incur price cutsFinancial Times - 2h -
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.CNBC - 2h -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - 4h -
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.The New York Times - 5h -
The next 15 drugs chosen for Medicare negotiation
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare ...The Hill - 4h -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - 4h -
The Biden administration eyes more drilling restrictions in Alaska
The Biden administration is setting in motion actions that could prevent drilling in more “special areas” of Alaska’s north slope — if the incoming Trump administration does not shelve it. The ...The Hill - 21h -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9
More from The Hill
-
Sam Altman claps back at Senate inquiry into Trump inaugural fund donation
OpenAI CEO and co-founder OpenAI clapped back at two Democratic senators' inquiry into his $1 million personal donation to President-elect Trump's inaugural fund, quipping on Friday he was not ...The Hill - 39m -
Kemp leads Ossoff in Georgia Senate matchup: GOP survey
Gov. Brian Kemp (R) holds a six-point lead over Sen. Jon Ossoff (D-Ga.) in a hypothetical matchup for the 2026 Georgia Senate race, according to an internal poll released by the conservative Club ...The Hill - 41m -
South Dakota tribe lifts Noem banishment from lands
The Flandreau Santee Sioux tribe announced Friday they were lifting restrictions on South Dakota Gov. Kristi Noem that barred her from stepping foot on their reservation land. The news comes as ...The Hill - 42m -
Southern California's next potential threat? Floods, landslides and toxic debris flows
As devastating wildfires continue to ravage the Los Angeles metropolitan region, local officials are warning of potential floods, landslides and toxic debris flows in the weeks and months ahead. ...The Hill - 49m -
Ramaswamy plans run for Ohio governor
Vivek Ramaswamy, the co-chair of President-elect Trump's new "Department of Government Efficiency" (DOGE), plans to run for governor of Ohio, two sources confirmed to The Hill on Friday. The Ohio ...The Hill - 57m
More in Politics
-
Sam Altman claps back at Senate inquiry into Trump inaugural fund donation
OpenAI CEO and co-founder OpenAI clapped back at two Democratic senators' inquiry into his $1 million personal donation to President-elect Trump's inaugural fund, quipping on Friday he was not ...The Hill - 39m -
Kemp leads Ossoff in Georgia Senate matchup: GOP survey
Gov. Brian Kemp (R) holds a six-point lead over Sen. Jon Ossoff (D-Ga.) in a hypothetical matchup for the 2026 Georgia Senate race, according to an internal poll released by the conservative Club ...The Hill - 41m -
South Dakota tribe lifts Noem banishment from lands
The Flandreau Santee Sioux tribe announced Friday they were lifting restrictions on South Dakota Gov. Kristi Noem that barred her from stepping foot on their reservation land. The news comes as ...The Hill - 42m -
Ohio Gov. DeWine appoints Lt. Gov. Husted to fill Vance's Senate seat
Ohio Gov. Mike DeWine has appointed Lt. Gov. Jon Husted to fill the Senate seat that was recently vacated by Vice President-elect JD Vance.NBC News - 44m -
Southern California's next potential threat? Floods, landslides and toxic debris flows
As devastating wildfires continue to ravage the Los Angeles metropolitan region, local officials are warning of potential floods, landslides and toxic debris flows in the weeks and months ahead. ...The Hill - 49m